(Total Views: 563)
Posted On: 05/19/2020 7:13:22 PM
Post# of 72447
So SRNE (Sorrento) has a market cap of a billion dollars, for an untested drug that hasn't even been tried in animals.
Go ahead, bashers, now tell us how IPIX is so overvalued with its multiple successful clinical trials for several applications of Brilacidin, plus Kevetrin.
Go ahead, bashers, now tell us how IPIX is so overvalued with its multiple successful clinical trials for several applications of Brilacidin, plus Kevetrin.
(4)
(0)
